Since its discovery in 2006, the IDCT Protocol has undergone continual research and clinical trials.

Immunocine’s Associated Publications

Our Immunotherapy Protocol was first discovered in 2006 within the prestigious Texas Medical Center. This research has continued and has ultimately resulted in active clinical trials studying the treatment of Glioblastoma and Pancreatic Ductal Adenocarcinoma.

The following research is specific to Immunocine’s unique Dendritic Cell Treatment, which is patented and the first of its kind. These publications provide both scientific validation of our Immunotherapy as well as review the treatment’s pre-clinical and clinical successes.

Start Your Personalized Treatment

1) Apply to See If You Qualify

If you meet the minimum requirements outlined above and are interested in seeing how our treatment could work for your specific case, please submit your info on our submission form or call us directly at +1 (888) 575-2572.

2) Schedule an Intro Call

Our team loves discussing our treatment with potential patients. We will schedule an intro call to learn about your diagnosis and answer any questions that you may have. Prior to the call, we will share additional info for you to review with your family and physician as you see fit.

3) Undergo Medical Evaluation

After confirming your eligibility, our Medical Team will perform a complimentary medical evaluation. This includes a questionnaire and review of your medical records. Once complete, you can be approved for treatment and we can build a personalized treatment program for you.